Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope

Supporting Information

• Supporting Information revision 3 - Revised Supporting Information in full-formatted PDF in response to reviewers comments.
• Supporting Video S1 - Supporting video describing results of molecular dynamics simulations. Title: MD trajectories illustrating peptide mobility.